Fluvoxamine is a potent inhibitor of tacrine metabolism

被引:0
|
作者
机构
关键词
Public Health; Plasma Concentration; Single Dose; Treatment Regimen; Clinical Pharmacology;
D O I
10.2165/00128415-199907670-00004
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [21] Effect of tacrine hydrochloride on hepatic drug metabolism
    Danbury, TC
    Eccles, M
    Ford, J
    Roberts, CJ
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (01) : 91 - 96
  • [22] A potent and selective tacrine analog - Biomembrane permeation and physicochemical characterization
    Patani, GA
    Pang, YP
    Chien, YW
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (04) : 525 - 538
  • [23] Effects of fluvoxamine on cerebral glucose metabolism in rats
    Freo, U
    Merico, A
    Pietrini, P
    Dam, M
    Ori, C
    Pizzolato, G
    Battistin, L
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 269 - 269
  • [24] Hepatic metabolism of cediranib, a potent VEGF inhibitor: Interspecies comparison and human enzymology
    Spear, Michael
    Pollard, Chris R. J.
    Pattison, Christine
    Kelly, Sarah
    Rollison, Helen
    Ward, Michelle
    Harrison, Mike P.
    Schulz-Utermoehl, Timothy
    DRUG METABOLISM REVIEWS, 2009, 41 : 146 - 146
  • [25] Preclinical pharmacokinetic and metabolism of apixaban, a potent and selective factor Xa inhibitor.
    He, Kan
    He, Bing
    Grace, James E.
    Xin, Baomin
    Zhang, Donglu
    Pinto, Donald J.
    Luettgen, Joseph M.
    Knabb, Robert M.
    Lam, Patrick Y. S.
    Wexler, Ruth R.
    Humphreys, William G.
    Shyu, Wen-Chyi
    Grossman, Scott J.
    BLOOD, 2006, 108 (11) : 273A - 273A
  • [26] Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver
    Peter Platzer
    Theresia Thalhammer
    Gerhard Hamilton
    Ernst Ulsperger
    Erwin Rosenberg
    Rene Wissiack
    Walter Jäger
    Cancer Chemotherapy and Pharmacology, 2000, 45 : 50 - 54
  • [27] EFFECT OF CHLORSULFURON, A POTENT INHIBITOR OF ACETOHYDROXYACID SYNTHASE, ON METABOLISM OF CLAVICEPS-PURPUREA
    MAIER, W
    SCHUMANN, B
    GROGER, D
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 1988, 43 (5-6): : 403 - 407
  • [28] SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression
    Mleczko-Sanecka, Katarzyna
    Casanovas, Guillem
    Ragab, Anan
    Breitkopf, Katja
    Mueller, Alexandra
    Boutros, Michael
    Dooley, Steven
    Hentze, Matthias W.
    Muckenthaler, Martina U.
    BLOOD, 2010, 115 (13) : 2657 - 2665
  • [29] In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acetylcholinesterase and Butyrylcholinesterase Inhibitor
    Liu, Wei
    Shi, Xiaoyuan
    Yang, Yadi
    Cheng, Xuemei
    Liu, Qing
    Han, Han
    Yang, Baohua
    He, Chunyong
    Wang, Yongli
    Jiang, Bo
    Wang, Zhengtao
    Wang, Changhong
    PLOS ONE, 2015, 10 (04):
  • [30] Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver
    Platzer, P
    Thalhammer, T
    Hamilton, G
    Ulsperger, E
    Rosenberg, E
    Wissiack, R
    Jäger, W
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (01) : 50 - 54